Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Nu-Med Plus (NUMD) Return on Equity (2016 - 2025)

Nu-Med Plus' Return on Equity history spans 9 years, with the latest figure at 0.08% for Q4 2021.

  • On a quarterly basis, Return on Equity rose 14.0% to 0.08% in Q4 2021 year-over-year; TTM through Dec 2021 was 0.08%, a 14.0% increase, with the full-year FY2021 number at 0.05%, up 37.0% from a year prior.
  • Return on Equity hit 0.08% in Q4 2021 for Nu-Med Plus, down from 0.34% in the prior quarter.
  • Over the last five years, Return on Equity for NUMD hit a ceiling of 1.49% in Q1 2018 and a floor of 1.51% in Q2 2018.
  • Historically, Return on Equity has averaged 0.02% across 5 years, with a median of 0.01% in 2017.
  • Biggest five-year swings in Return on Equity: plummeted -150bps in 2018 and later skyrocketed 157bps in 2019.
  • Tracing NUMD's Return on Equity over 5 years: stood at 0.64% in 2017, then plummeted by -115bps to 0.1% in 2018, then surged by 131bps to 0.03% in 2019, then tumbled by -294bps to 0.06% in 2020, then skyrocketed by 241bps to 0.08% in 2021.
  • Business Quant data shows Return on Equity for NUMD at 0.08% in Q4 2021, 0.34% in Q3 2021, and 0.17% in Q2 2021.